Search

Displaying results 8701 - 8710 of 10000 in total
  1. Drug

    Imisopasem manganese

    go.drugbank.com/drugs/DB04976
    Investigational

    M40403 is a low molecular weight, synthetic manganese containing superoxide dismutase mimetic (SODm) that selectively removes superoxide anion.

  2. Drug

    Alpha-galactosylceramide

    go.drugbank.com/drugs/DB12232
    Investigational

    KRN7000 has been used in trials studying the treatment of Lung Cancer, Chronic Hepatitis C, Hepatitis B, Chronic, Unspecified Adult Solid Tumor, Protocol Specific, and Prevention of GvHD in Patients With

  3. Drug

    Ternidazole

    go.drugbank.com/drugs/DB19951
    Experimental

    The usage of the INN stem '-nidazole' in the name indicates that Ternidazole is a antiprotozoal and radiosensitizer, metronidazole derivative.

  4. Drug

    Bamnidazole

    go.drugbank.com/drugs/DB19965
    Experimental

    The usage of the INN stem '-nidazole' in the name indicates that Bamnidazole is a antiprotozoal and radiosensitizer, metronidazole derivative.

  5. Drug

    Lificiguat

    go.drugbank.com/drugs/DB19979
    Experimental

    The usage of the INN stem '-ciguat' in the name indicates that Lificiguat is a guanylate cyclase activator and stimulator. Lificiguat has a monoisotopic molecular weight of 304.12 Da.

  6. Drug

    Poloxalene

    go.drugbank.com/drugs/DB11451
    InvestigationalVet approved

    These are compounds containing a cyclic ether with three ring atoms (one oxygen and two carbon atoms).

  7. Drug

    IMCY-0141

    go.drugbank.com/drugs/DB17019
    Investigational

    IMCY-0141 is a synthetic peptide based on MOG (Myelin Oligodendrocyte Glycoprotein), a dominant autoantigen, designed to stop the progression of multiple sclerosis (MS) and the destruction of the myelin

  8. Drug

    Cofirasersen

    go.drugbank.com/drugs/DB19037
    Investigational

    Cofirasersen is under investigation in clinical trial NCT04441788 (A Study to Assess the Safety, Tolerability, and Efficacy of ION-827359 in Participants With Mild to Moderate Chronic Obstructive Pulmonary

  9. Drug

    Maytansine

    go.drugbank.com/drugs/DB19582
    Investigational

    Maytansine is under investigation in clinical trial NCT04189211 (A Clinical Trial of BAT8001 on Safety, Tolerability and Pharmacokinetics for Patients).

  10. Drug

    Afizagabar

    go.drugbank.com/drugs/DB21439
    Investigational

    Afizagabar is under investigation in clinical trial NCT02877615 (Efficacy and Safety Trial With S 44819 After Recent Ischemic Cerebral Event).